Fatty acid synthase inhibitor cerulenin hinders liver cancer stem cell properties through FASN/APP axis as novel therapeutic strategies
Hepatocellular carcinoma (HCC) poses significant treatment challenges due to high postoperative recurrence rates and the limited effectiveness of targeted medications. Researchers have identified the unique metabolic profiles of cancer stem cells (CSCs) as the primary drivers of cancer recurrence, m...
Saved in:
| Main Authors: | Liang-Yun Chen, Dao-Sian Wu, Yao-An Shen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | Journal of Lipid Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227524001652 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer
by: Travis Vander Steen, et al.
Published: (2025-04-01) -
Deletion of Murine APP Aggravates Tau and Amyloid Pathologies in the 5xFADXTg30 Alzheimer’s Disease Model
by: Kunie Ando, et al.
Published: (2025-01-01) -
Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus
by: Hayder M. Al‐kuraishy, et al.
Published: (2025-03-01) -
Longitudinal characterization reveals behavioral impairments in aged APP knock in mouse models
by: Lisa Blackmer-Raynolds, et al.
Published: (2025-02-01) -
APP β-CTF triggers cell-autonomous synaptic toxicity independent of Aβ
by: Mengxun Luo, et al.
Published: (2025-04-01)